Key clinical point: Despite starting a statin or antihypertensive drug, people can regress on other cardiovascular disease risks factors like body mass and inactivity.

Major finding: Nonobese people starting statin or antihypertensive treatment had a 82% higher incidence of obesity than those not starting these drugs.

Study details: A review of prospectively collected data from 41,225 adults in the Finnish Public Sector Study.

Disclosures: The study received no commercial funding. Dr. Korhonen had no disclosures.